Wu Lianpeng, Cai Xiyue, Xu Shuya, Lin Xuefeng, Wu Shuangliao, Xu Xueqin
Department of Clinical Laboratory Medicine, The Ding Li Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, Wenzhou, China.
Key Laboratory of Diagnosis and Treatment of New and Recurrent Infectious Diseases of Wenzhou, Wenzhou Sixth People's Hospital, Wenzhou, China.
Front Public Health. 2025 Aug 15;13:1600214. doi: 10.3389/fpubh.2025.1600214. eCollection 2025.
This study aimed to analyze the epidemiological characteristics and trends of notified multidrug-resistant tuberculosis (MDR-TB) in Wenzhou City, China, from 2014 to 2023, with a focus on differences between migrant and local populations among reported TB cases.
This was a facility-based retrospective cohort study that included all bacteriologically confirmed TB cases notified between 1 January 2014 and 31 December 2023 in the Tuberculosis Information Management System (TBIMS) of the Chinese Center for Disease Control and Prevention and the hospital's laboratory information system, provided they had available phenotypic drug-susceptibility testing (pDST) results. Pearson's chi-square test was used to compare drug-resistance rates between groups, the trend chi-square test was applied to assess temporal changes, and a Sankey diagram was employed to illustrate the origins and intra-city distribution of MDR-TB among the migrant population.
Among 10,993 notified TB patients, 734 (6.68%) were classified as MDR-TB. The proportion of MDR-TB among notified cases declined over the study period ( < 0.001). Nearly half (352/734; 47.96%) of the notified MDR-TB patients were migrants; 226 (64.21%) originated from elsewhere in Zhejiang Province, and 126 (35.79%) came from outside the province. Guizhou, Jiangxi and Sichuan were the leading external contributors. Within Wenzhou, Yueqing City, Yongjia County and Ouhai District reported the highest numbers of migrant MDR-TB notifications.
The proportion of MDR-TB among notified TB cases in Wenzhou City has steadily decreased. Migrants account for almost half of these notified MDR-TB cases. Surveillance-driven and migrant-targeted interventions should be prioritized to further reduce MDR-TB transmission.
本研究旨在分析2014年至2023年中国温州市报告的耐多药结核病(MDR-TB)的流行病学特征和趋势,重点关注报告的结核病病例中流动人口与本地人口之间的差异。
这是一项基于机构的回顾性队列研究,纳入了2014年1月1日至2023年12月31日在中国疾病预防控制中心结核病信息管理系统(TBIMS)和医院实验室信息系统中报告的所有细菌学确诊的结核病病例,前提是他们有可用的表型药敏试验(pDST)结果。采用Pearson卡方检验比较组间耐药率,应用趋势卡方检验评估时间变化,并使用桑基图说明流动人口中耐多药结核病的来源和市内分布。
在10993例报告的结核病患者中,734例(6.68%)被归类为耐多药结核病。在研究期间,报告病例中耐多药结核病的比例有所下降(<0.001)。近一半(352/734;47.96%)的报告耐多药结核病患者为流动人口;226例(64.21%)来自浙江省其他地区,126例(35.79%)来自省外。贵州、江西和四川是主要的省外来源地。在温州市内,乐清市、永嘉县和瓯海区报告的流动人口耐多药结核病病例数最多。
温州市报告的结核病病例中耐多药结核病的比例稳步下降。流动人口占这些报告的耐多药结核病病例的近一半。应优先采取以监测为导向、针对流动人口的干预措施,以进一步减少耐多药结核病的传播。